Lake Street says AMT-130 could be ‘significantly impactful’ for ClearPoint

finance.yahoo.com/news/lake-street-says-amt-130-125519431.html

In This Article:
After uniQure (QURE) provided a regulatory update on AMT-130, its investigational gene therapy for the treatment of Huntington’s disease, and said the company has reached alignment with the FDA to support the accelerated approval pathway, Lake Street said that AMT-130 is…

This story appeared on finance.yahoo.com, 2025-06-04 12:55:19.
The Entire Business World on a Single Page. Free to Use →